The conference has applied for European CME credits (ECMEC) with the European Accreditation Council for Continuing Medical Education (EACCME). Information on granted credits will be provided as soon as available.
The 5th ImmunoTherapy of Cancer Conference adheres to the Code of Practice and supports the Eucomed Guidelines on Interactions with Healthcare Professionals (EthicalMedTech).
Ethical Med Tech: Conference Vetting System
The Conference Vetting System is a unique initiative in the healthcare industry. Launched beginning of 2012, this independently managed system reviews the compliance of third-party educational conferences with the Eucomed Code of Ethical Business Practice (the “Code”) to determine the appropriateness for companies which are members of Eucomed and members of the national associations affiliated with Eucomed to sponsor Healthcare Professionals to participate in such conferences.
The Conference Vetting System is a centralised decision-making system that encourages transparency and consistency in medical conferences and alleviates the complex administrative burden previously faced by Eucomed members, who were constrained to make their own determinations on whether or not a conference is compliant with the Code.
For further details please visit the Ethical MedTech Website